RxDoctor Payments Data

Edward Braun, MD

Pain Medicine · Kansas City, KSNPI 1821192956

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,275 of the $11,578 with a category attached, or 88.7%. 15 manufacturers reported payments, led by Abbott at 45.9% of the total. Reporting peaked in 2023 at $3,427 and has fallen 63.8% since, to $1,242 in 2025.

$11,578in general payments, 2019–2025

Across 197 payments — averaging $58.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Saluda Medical Americas, Inc.$3K
  • Nevro Corp.$2K
  • Medtronic$271
  • SPR Therapeutics, Inc$263
  • Globus Medical$245
  • plus $1K from 9 others
$151,666in research payments, 2019–2025

Across 30 payments — averaging $5055.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$152K

What the payments were for

  • Travel & lodging$1,30411%
  • Food & beverage$10,27589%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,578 in reported general payments places this provider in the 70th percentile of 64 pain medicine providers in Kansas.

See all pain medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$157,373
Medicare patients
436
Services billed
1,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl13$28,472
Gabapentin453$8,411
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen217$7,896
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen319$7,797
Pregabalin160$3,983
Tizanidine Hcl309$3,946
Fentanyl31$3,441
Morphine Sulfate37$1,634
Tramadol Hcl250$1,512
Oxycodone Hcl119$1,501
Lidocaine14$1,318
Cyclobenzaprine Hcl102$1,094
Methocarbamol44$1,030
Diclofenac Sodium15$520
Nortriptyline Hcl24$436

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →